Thrive Bioscience, Inc. — Form D
Thrive Bioscience, Inc. of Wakefield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-28. The offering totals $2.5M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-28
- Form: D
- Accession: 0001642601-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.8M
- Remaining: $698K
- Minimum investment: $100K
- Investors: 21
- Date of first sale: 2017-05-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-293560
Issuer
- Name: Thrive Bioscience, Inc.
- CIK: 0001642601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11 Audubon Road, Wakefield, MA, 01880
- Phone: 9787208046
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Alan Philippe Blanchard | Director | Wakefield, MA |
| Guy Philippe Broadbent | Director | Wakefield, MA |
| Thomas Forest Farb | Director | Wakefield, MA |
| Michael Philippe Finney | Director | Wakefield, MA |
| Brock Philippe Reeve | Director | Wakefield, MA |
| Alan Philippe Blanchard | Executive Officer | Wakefield, MA |
| Thomas Forest Farb | Executive Officer | Wakefield, MA |
| Michael Forest Finney | Director | Beverly, MA |
| Gary Paul Magnant | Director | Beverly, MA |
| Gary Paul Magnant | Executive Officer | Beverly, MA |
Other filings by this issuer (3)
More